ERCC2 and non-small cell lung carcinoma: The ERCC2 rs50872 T allele was associated with a favorable survival outcome for advanced NSCLC patients, and these effects were mainly seen in male patients, elder patients, and in patients without surgery but who underwent chemotherapy or radiotherapy.